+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cell cycle independent infection and gene transfer by recombinant Sendai viruses



Cell cycle independent infection and gene transfer by recombinant Sendai viruses



Journal of Virological Methods 108(2): 229-233



A common problem for viral vectors in the field of somatic gene therapy is the dependence of an efficient cellular transduction on the cell cycle phase of target cells. An optimized viral vector system should therefore transduce cells in different cell cycle phases equally to improve transduction efficiencies. Recent observations that recombinant Sendai viruses (SeV) can infect a broad range of different tissues suggested SeV to be a good candidate for future gene therapeutic strategies in which dividing and non-dividing cells have to be reached. However, detailed data on the influence of distinct cell cycle phases on the infection of SeV or related viruses are missing. We report that synchronization of NIH 3T3 cells as well as contact inhibition of human fibroblast cells did not exhibit any negative influence on SeV infection rates. Furthermore, different attractive target tissues like human umbilical cord derived cells or primary human hepatocytes can be reached by SeV efficiently. As an important information for further cell cycle studies of paramyxoviruses we discovered surprisingly that the DNA polymerase inhibitor aphidicolin (induces a G(1)/M arrest) functions as an inhibitor of SeV but not of an adenoviral expression vector. In conclusion, the results demonstrate SeV based vector particles to be an ideal tool to reach equally cells coexisting in different cell cycle phases.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010284543

Download citation: RISBibTeXText

PMID: 12609691

DOI: 10.1016/s0166-0934(02)00280-x


Related references

Characterization of Sendai virus persistently infected L929 cells and Sendai virus pi strain: recombinant Sendai viruses having Mpi protein shows lower cytotoxicity and are incapable of establishing persistent infection. Virology 314(1): 0-24, 2003

Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus. Journal of Virology 85(6): 2771-2780, 2011

Rescue of Sendai virus from viral ribonucleoprotein-transfected cells by infection with recombinant vaccinia viruses carrying Sendai virus L and P/C genes. Virology 171(2): 434-443, 1989

Recombinant Sendai virus-mediated gene transfer into adult rat retinal tissue: Efficient gene transfer by brief exposure. Experimental Eye Research 75(1): 39-48, 2002

Recombinant Sendai virus-mediated gene transfer to vasculature: a new class of efficient gene transfer vector to the vascular system. Faseb Journal 15(7): 1294-1296, 2001

Recombinant Sendai viruses expressing different levels of a foreign reporter gene. Virus Research 86(1-2): 33-38, 2002

Recombinant Sendai viruses with L1618V mutation in their L polymerase protein establish persistent infection, but not temperature sensitivity. Virology 329(2): 289-301, 2004

Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nature Biotechnology 18(9): 970-973, 2000

Asialoglycoprotein -restricted gene transfer by recombinant Sendai virus vectors. Hepatology 28(4 Part 2): 519A, 1998

Recombinant Sendai virus for efficient gene transfer to human airway epithelium. Experimental Lung Research 30(2): 83-96, 2004

Recombinant Sendai virus vector mediated gene transfer targeting kidney. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 407A-408A, 2000